Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/33997
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-09-24T13:01:20Z | - |
dc.date.available | 2023-09-24T13:01:20Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | Bülbül, Y. vd. (2017). ''Assessment of palliative care in lung cancer in Turkey''. Medical Principles and Practice, 26(1), 50-56. | en_US |
dc.identifier.issn | 1011-7571 | - |
dc.identifier.issn | 1423-0151 | - |
dc.identifier.uri | https://doi.org/10.1159/000452801 | - |
dc.identifier.uri | https://karger.com/mpp/article/26/1/50/207403/Assessment-of-Palliative-Care-in-Lung-Cancer-in | - |
dc.identifier.uri | http://hdl.handle.net/11452/33997 | - |
dc.description | Çalışmada 43 yazar bulunmaktadır. Bu yazarlardan sadece Bursa Uludağ Üniversitesi mensuplarının girişleri yapılmıştır. | tr_TR |
dc.description.abstract | Objective: To investigate the symptoms of lung cancer in Turkey and to evaluate approaches to alleviate these symptoms. Subjects and Methods: This study included 1,245 lung cancer patients from 26 centers in Turkey. Demographic characteristics as well as information regarding the disease and treatments were obtained from medical records and patient interviews. Symptoms were evaluated using the Edmonton Symptom Assessment Scale (ESAS) and were graded on a scale between 0 and 10 points. Data were compared using the. 2, Student t, and Mann-Whitney U tests. Potential predictors of symptoms were analyzed using logistic regression analysis. Results: The most common symptom was tiredness (n = 1,002; 82.1%), followed by dyspnea (n = 845; 69.3%), appetite loss (n = 801; 65.7%), pain (n = 798; 65.4%), drowsiness (n = 742; 60.8%), anxiety (n = 704; 57.7%), depression (n = 623; 51.1%), and nausea (n = 557; 45.5%). Of the 1,245 patients, 590 (48.4%) had difficulty in initiating or maintaining sleep. The symptoms were more severe in stages III and IV. Logistic regression analysis indicated a clear association between demographic characteristics and symptom distress, as well as between symptom distress (except nausea) and well-being. Overall, 804 (65.4%) patients used analgesics, 630 (51.5%) received treatment for dyspnea, 242 (19.8%) used enteral/parenteral nutrition, 132 (10.8%) used appetite stimulants, and 129 (10.6%) used anxiolytics/antidepressants. Of the 799 patients who received analgesics, 173 (21.7%) reported that their symptoms were under control, and also those on other various treatment modalities (dyspnea: 78/627 [12.4%], appetite stimulant: 25/132 [18.9%], and anxiolytics/antidepressants: 25/129 [19.4%]) reported that their symptoms were controlled. Conclusion: In this study, the symptoms progressed and became more severe in the advanced stages of lung cancer, and palliative treatment was insufficient in most of the patients in Turkey. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Karger | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | General &iInternal medicine | en_US |
dc.subject | Lung cancer | en_US |
dc.subject | Palliation | en_US |
dc.subject | Palliative treatment | en_US |
dc.subject | Symptoms | en_US |
dc.subject | Treatment | en_US |
dc.subject | Quality-of-life | en_US |
dc.subject | Sleep disturbances | en_US |
dc.subject | Symptom experience | en_US |
dc.subject | Supportive care | en_US |
dc.subject | Pain | en_US |
dc.subject | Chemotherapy | en_US |
dc.subject | Prevalence | en_US |
dc.subject | Impact | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Analgesics | en_US |
dc.subject.mesh | Comorbidity | en_US |
dc.subject.mesh | Dyspnea | en_US |
dc.subject.mesh | Fatigue | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Interviews as topic | en_US |
dc.subject.mesh | Logistic models | en_US |
dc.subject.mesh | Lung neoplasms | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Neoplasm staging | en_US |
dc.subject.mesh | Neoplasms | en_US |
dc.subject.mesh | Squamous cell | en_US |
dc.subject.mesh | Pain | en_US |
dc.subject.mesh | Palliative care | en_US |
dc.subject.mesh | Quality of Life | en_US |
dc.subject.mesh | Turkey | en_US |
dc.title | Assessment of palliative care in lung cancer in Turkey | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000391457100008 | tr_TR |
dc.identifier.scopus | 2-s2.0-84992688577 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Göğüs Cerrahisi Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 50 | tr_TR |
dc.identifier.endpage | 56 | tr_TR |
dc.identifier.volume | 26 | tr_TR |
dc.identifier.issue | 1 | tr_TR |
dc.relation.journal | Medical Principles and Practice | en_US |
dc.contributor.buuauthor | Erol, Mehmet Muharrem | - |
dc.contributor.researcherid | CPM-5715-2022 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.identifier.pubmed | 27780164 | tr_TR |
dc.subject.wos | Medicine, general & internal | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q2 | en_US |
dc.contributor.scopusid | 35605916500 | tr_TR |
dc.subject.scopus | Childhood Cancer Survivor; Sleep Disorders; Breast Neoplasms | en_US |
dc.subject.emtree | Antidepressant agent | en_US |
dc.subject.emtree | Anxiolytic agent | en_US |
dc.subject.emtree | Appetite stimulant | en_US |
dc.subject.emtree | Bisphosphonic acid derivative | en_US |
dc.subject.emtree | Bronchodilating agent | en_US |
dc.subject.emtree | Cyproheptadine | en_US |
dc.subject.emtree | Fentanyl | en_US |
dc.subject.emtree | Megestrol acetate | en_US |
dc.subject.emtree | Morphine | en_US |
dc.subject.emtree | Nonsteroid antiinflammatory agent | en_US |
dc.subject.emtree | Paracetamol | en_US |
dc.subject.emtree | Sedative agent | en_US |
dc.subject.emtree | Tramadol | en_US |
dc.subject.emtree | Vitamin | en_US |
dc.subject.emtree | Analgesic agent | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Analgesia | en_US |
dc.subject.emtree | Anxiety disorder | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Bone metastasis | en_US |
dc.subject.emtree | Cachexia | en_US |
dc.subject.emtree | Cancer fatigue | en_US |
dc.subject.emtree | Cancer pain | en_US |
dc.subject.emtree | Cancer palliative therapy | en_US |
dc.subject.emtree | Cancer patient | en_US |
dc.subject.emtree | Cancer radiotherapy | en_US |
dc.subject.emtree | Combination drug therapy | en_US |
dc.subject.emtree | Comparative study | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Depression | en_US |
dc.subject.emtree | Drowsiness | en_US |
dc.subject.emtree | Dysphagia | en_US |
dc.subject.emtree | Dyspnea | en_US |
dc.subject.emtree | Edmonton symptom assessment scale | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Loss of appetite | en_US |
dc.subject.emtree | Lung cancer | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Middle aged | en_US |
dc.subject.emtree | Nasogastric tube | en_US |
dc.subject.emtree | Nausea | en_US |
dc.subject.emtree | Nebulizer | en_US |
dc.subject.emtree | Noninvasive ventilation | en_US |
dc.subject.emtree | Disease severity | en_US |
dc.subject.emtree | Nutritional support | en_US |
dc.subject.emtree | Oxygen therapy | en_US |
dc.subject.emtree | Pain severity | en_US |
dc.subject.emtree | Parenteral nutrition | en_US |
dc.subject.emtree | Percutaneous endoscopic gastrostomy | en_US |
dc.subject.emtree | Pleurodesis | en_US |
dc.subject.emtree | Prospective study | en_US |
dc.subject.emtree | Psychopharmacotherapy | en_US |
dc.subject.emtree | Sleep disorder | en_US |
dc.subject.emtree | Stent | en_US |
dc.subject.emtree | Symptom assessment | en_US |
dc.subject.emtree | Thoracocentesis | en_US |
dc.subject.emtree | Turkey (republic) | en_US |
dc.subject.emtree | Vitamin supplementation | en_US |
dc.subject.emtree | Wellbeing | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Cancer staging | en_US |
dc.subject.emtree | Complication | en_US |
dc.subject.emtree | Dyspnea | en_US |
dc.subject.emtree | Fatigue | en_US |
dc.subject.emtree | Interview | en_US |
dc.subject.emtree | Lung neoplasms | en_US |
dc.subject.emtree | Pain | en_US |
dc.subject.emtree | Palliative therapy | en_US |
dc.subject.emtree | Psychology | en_US |
dc.subject.emtree | Quality of life | en_US |
dc.subject.emtree | Squamous cell carcinoma | en_US |
dc.subject.emtree | Statistical model | en_US |
dc.subject.emtree | Turkey | en_US |
dc.subject.emtree | Comorbidity | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Erol_vd_2017.pdf | 158.03 kB | Adobe PDF | ![]() View/Open |
This item is licensed under a Creative Commons License